Timeliness of Postmarket Studies for New Pharmaceuticals Approved Between 2009 and 2012: a Cross-Sectional Analysis

J Gen Intern Med. 2019 Apr;34(4):492-495. doi: 10.1007/s11606-018-4779-x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Clinical Trials as Topic
  • Cross-Sectional Studies
  • Drug Approval / statistics & numerical data*
  • Humans
  • Product Surveillance, Postmarketing / standards*
  • Time Factors
  • United States
  • United States Food and Drug Administration / organization & administration